Literature DB >> 31821719

Primrose syndrome associated with unclassified immunodeficiency and a novel ZBTB20 mutation.

Keiko Yamamoto-Shimojima1,2,3, Taichi Imaizumi2,4, Hiroyuki Akagawa3, Hitoshi Kanno2,5, Toshiyuki Yamamoto2,3,4.   

Abstract

Primrose syndrome is a congenital malformation syndrome characterized by intellectual disability, developmental delay, progressive muscle wasting, and ear lobe calcification. Mutations in the ZBTB20 gene have been established as being accountable for this syndrome. In this study, a novel de novo ZBTB20 mutation, NM_001164342.2:c.1945C>T (p.Leu649Phe), has been identified through whole exome sequencing (WES) in a female patient presenting a typical Primrose phenotype. Because the present patient exhibited recurrent otitis media, detailed immunological examinations were performed in this study and subnormal immunoglobulin levels were firstly identified in a Primrose patient. Anatomical anomaly of the inner ear has never been reported in this patient and WES data did not include any relevant variants causally linked with the immunologic defect. Thus, there is a possibility of a relation between an unclassified immunodeficiency with selective IgG2 deficiency and Primrose syndrome and this may be the reason of recurrent otitis media frequently observed in Primrose patients. Because subnormal levels of IgG2 in this patient might be caused by an unrelated and still uncharacterized genetic cause, further studies are required to prove the causal link between aberrant ZBTB20 function and immunodeficiency.
© 2019 Wiley Periodicals, Inc.

Entities:  

Keywords:  array-based comparative genomic hybridization analysis; corpus callosum; developmental delay; macrocephaly; unclassified immunodeficiency

Mesh:

Substances:

Year:  2019        PMID: 31821719     DOI: 10.1002/ajmg.a.61432

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.802


  1 in total

1.  Primrose syndrome: Characterization of the phenotype in 42 patients.

Authors:  Daniela Melis; Daniel Carvalho; Tina Barbaro-Dieber; Alberto J Espay; Michael J Gambello; Blanca Gener; Erica Gerkes; Marrit M Hitzert; Hanne B Hove; Sandra Jansen; Petr E Jira; Katherine Lachlan; Leonie A Menke; Vinodh Narayanan; Damara Ortiz; Eline Overwater; Renata Posmyk; Keri Ramsey; Alessandro Rossi; Renata Lazari Sandoval; Constance Stumpel; Kyra E Stuurman; Viviana Cordeddu; Peter Turnpenny; Pietro Strisciuglio; Marco Tartaglia; Sheela Unger; Todd Waters; Clare Turnbull; Raoul C Hennekam
Journal:  Clin Genet       Date:  2020-04-20       Impact factor: 4.438

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.